Company Information

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE632.400.5 (+0.08 %)
PREV CLOSE ( ) 631.90
OPEN PRICE ( ) 637.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 407
TODAY'S LOW / HIGH ( )629.50 641.15
52 WK LOW / HIGH ( )548.05 789.95
NSE632.75-1.3 (-0.21 %)
PREV CLOSE( ) 634.05
OPEN PRICE ( ) 635.00
BID PRICE (QTY) 632.75 (14)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8935
TODAY'S LOW / HIGH( ) 628.65 641.90
52 WK LOW / HIGH ( )544.1 790.95
ChairmanS Sambhu Prasad
Managing DirectorS Sambhu Prasad
Company SecretaryGagan Preet Singh
Non Executive Independent DirectorRaja Venkataraman
S Muralidharan
Meenalochani Raghunathan
V Nagaraj
Non Independent & Non Executive DirectorRamaa Prabhakar Arikirevula
Incorporation Year : 09-09 1936

Registered Office :

Address : New 103 (Old 42-45),Luz Church Road,Mylapore Chennai,
Tamil Nadu-600004 .

Phone : 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.